TY - JOUR
T1 - Better adherence with out-of-hospital healthcare improved long-term prognosis of acute coronary syndromes
T2 - Evidence from an Italian real-world investigation
AU - Rea, Federico
AU - Ronco, Raffaella
AU - Pedretti, Roberto F.E.
AU - Merlino, Luca
AU - Corrao, Giovanni
N1 - Funding Information:
This study was supported by grants from the Italian Ministry of the Education, University and Research (’Fondo d'Ateneo per la Ricerca’ portion, year 2018), and from the Italian Ministry of Health (‘Ricerca Finalizzata 2016’, NET- 2016-02363853 ). The funding sources had no role in the design of the study, the collection, analysis and interpretation of the data, or the decision to approve publication of the finished manuscript.
Funding Information:
This study was supported by grants from the Italian Ministry of the Education, University and Research (?Fondo d'Ateneo per la Ricerca? portion, year 2018), and from the Italian Ministry of Health (?Ricerca Finalizzata 2016?, NET- 2016-02363853). The funding sources had no role in the design of the study, the collection, analysis and interpretation of the data, or the decision to approve publication of the finished manuscript.Giovanni Corrao received research support from the European Community (EC), the Italian Agency of Drug (AIFA), and the Italian Ministry of Education, University and Research (MIUR). He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN and BMS). He also received honoraria as member of Advisory Board from Roche.
Funding Information:
Giovanni Corrao received research support from the European Community (EC) , the Italian Agency of Drug (AIFA) , and the Italian Ministry of Education, University and Research (MIUR). He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN and BMS). He also received honoraria as member of Advisory Board from Roche.
Publisher Copyright:
© 2020
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/11/1
Y1 - 2020/11/1
N2 - Background: Patients who experience a hospital admission for acute coronary syndromes (ACS) exhibit poor prognosis over the years. The purposes of this study were to evaluate the real-world patterns of out-of-hospital practice in the management of ACS patients and to assess their impact on the risk of selected outcomes. Methods: The cohort of 87,530 residents in the Lombardy Region (Italy) who were newly hospitalised for ACS during 2011–2015 was followed until 2018. Exposure to medical treatment including use of selected drugs, diagnostic procedures and laboratory tests was recorded. The main outcome of interest was re-hospitalisation for cardiovascular (CV) outcomes. Proportional hazards models were fitted to estimate hazard ratio, and 95% confidence intervals (CI), for the exposure-outcome association. Analyses were stratified according to the ACS type. Results: The cumulative incidence of re-hospitalisation for CV disease was 33%, 42% and 38% at 5 years after index discharge among STEMI, NSTEMI and unstable angina patients. Within one year from index discharge, between 70% and 80% of patients had at least a prescription of statins, beta-blockers and renin–angiotensin-system blocking agents, underwent ECG and lipid profile examination, and had a cardiologic examination. One patient in five underwent cardiac rehabilitation. Compared with patients who did not adhere to healthcare recommendations, the risk of CV hospital readmission was reduced from 10% (95% CI: 4%–10%) to 23% (12%–32%) among patients who underwent lipid profile examinations and who experienced cardiac rehabilitation. Conclusion: Close out-of-hospital healthcare must be considered the cornerstone for improving the long-term prognosis of ACS patients.
AB - Background: Patients who experience a hospital admission for acute coronary syndromes (ACS) exhibit poor prognosis over the years. The purposes of this study were to evaluate the real-world patterns of out-of-hospital practice in the management of ACS patients and to assess their impact on the risk of selected outcomes. Methods: The cohort of 87,530 residents in the Lombardy Region (Italy) who were newly hospitalised for ACS during 2011–2015 was followed until 2018. Exposure to medical treatment including use of selected drugs, diagnostic procedures and laboratory tests was recorded. The main outcome of interest was re-hospitalisation for cardiovascular (CV) outcomes. Proportional hazards models were fitted to estimate hazard ratio, and 95% confidence intervals (CI), for the exposure-outcome association. Analyses were stratified according to the ACS type. Results: The cumulative incidence of re-hospitalisation for CV disease was 33%, 42% and 38% at 5 years after index discharge among STEMI, NSTEMI and unstable angina patients. Within one year from index discharge, between 70% and 80% of patients had at least a prescription of statins, beta-blockers and renin–angiotensin-system blocking agents, underwent ECG and lipid profile examination, and had a cardiologic examination. One patient in five underwent cardiac rehabilitation. Compared with patients who did not adhere to healthcare recommendations, the risk of CV hospital readmission was reduced from 10% (95% CI: 4%–10%) to 23% (12%–32%) among patients who underwent lipid profile examinations and who experienced cardiac rehabilitation. Conclusion: Close out-of-hospital healthcare must be considered the cornerstone for improving the long-term prognosis of ACS patients.
KW - Acute coronary syndromes
KW - Cardiac rehabilitation
KW - Cardiovascular disease
KW - Evidence-based recommendations
KW - Healthcare utilisation database
UR - http://www.scopus.com/inward/record.url?scp=85087494279&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087494279&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2020.06.017
DO - 10.1016/j.ijcard.2020.06.017
M3 - Article
C2 - 32593725
AN - SCOPUS:85087494279
VL - 318
SP - 14
EP - 20
JO - International Journal of Cardiology
JF - International Journal of Cardiology
SN - 0167-5273
ER -